GATA1 and acute megakaryoblastic leukemia: The pronounced differences in clinical outcomes between DS and non-DS AMKL patients and differences in the GATA1 gene mutation status in blast cells suggest a potential role for GATA1 in chemotherapy response in both DS and non-DS AMKL cases.